19
total announcements
544350.BO · 15 min delayed
Dr. Agarwals Health Care Ltd
Dr. Agarwals Health Care Ltd has published a newspaper advertisement for its 16th Annual General Meeting (AGM) to be held on September 21, 2026, through video conferencing. The notice is also available on the company's website.
Dr. Agarwals Health Care Ltd
Dr. Agarwals Health Care Ltd has submitted its Annual Report for the Financial Year 2025-26, along with a notice convening the Sixteenth Annual General Meeting (AGM) to be held on September 21, 2026, through video conferencing.
Dr. Agarwals Health Care Ltd
Dr. Agarwals Health Care Ltd has announced the notice convening the Sixteenth Annual General Meeting (AGM) to be held on September 21, 2026, along with the Annual Report for the financial year 2025-26.
Dr. Agarwals Health Care Ltd
Dr. Agarwals Health Care Ltd's subsidiary, Dr. Agarwal's Eye Hospital Limited, has launched the World's First Pinhole Pupilloplasty (PPP) Centre at its flagship facility in Chennai, marking an important step in advancing access to innovative, tissue-preserving solutions for selected patients affected by complex corneal conditions.
Dr. Agarwals Health Care Ltd
Dr. Agarwals Health Care Ltd has announced a schedule of analyst/investor meets on September 16-18, 2026, in Gurgaon and Mumbai, where company officials will participate in one-on-one meetings and conferences.
Dr. Agarwals Health Care Ltd
Catalyst Trusteeship Ltd has created a pledge over 7,538,303 equity shares of Dr. Agarwal's Health Care Ltd, constituting 2.38% of the issued and paid-up share capital, as part of a facility agreement with Hyperion Investments Pte. Ltd.
Dr. Agarwals Health Care Ltd
Dr. Agarwals Health Care Ltd has received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from DB International Trust (Singapore) Ltd, indicating a change in shareholding due to a sale/disposal of 24,160,000 equity shares by Hyperion Investments Pte. Ltd, a borrower under a facility agreement.
Dr. Agarwals Health Care Ltd
Claymore Investments (Mauritius) Pte. Ltd. has disclosed a sale of 1,59,00,000 shares of Dr. Agarwals Health Care Ltd, reducing their stake from 20.06% to 15.04%.
Dr. Agarwals Health Care Ltd
Dr. Agarwals Health Care Ltd has received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Hyperion Investments Pte. Ltd. regarding the sale of 24,160,000 equity shares of the company. The acquisition represents a 7.57% stake in the company.
Dr. Agarwals Health Care Ltd
Dr. Agarwals Health Care Ltd has received a disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Invesco Mutual Fund, indicating a potential change in control or significant stake acquisition.
Dr. Agarwals Health Care Ltd
Catalyst Trusteeship Ltd has released an encumbrance over 31,698,303 shares of Dr. Agarwals Health Care Ltd, reducing the total shares encumbered to 41,495,685.
Dr. Agarwals Health Care Ltd
Dr. Agarwals Health Care Ltd has made a disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, indicating a potential change in control or substantial acquisition of shares.
Dr. Agarwals Health Care Ltd
Dr. Agarwal's Healthcare Limited has announced its unaudited financial results for the quarter ended June 30, 2026, with a total income of INR620 crores, a 24% year-on-year growth, and revenue from operations of INR614 crores, a 26% year-on-year growth. The company has also expanded its footprint by commissioning 18 new greenfield facilities, strengthening its reach and capacity.
Dr. Agarwals Health Care Ltd
Dr. Agarwal's Health Care Limited has submitted a Monitoring Agency Report for the quarter ended June 30, 2026, as required by SEBI regulations, indicating that the utilization of the IPO proceeds is in line with the objects of the issue.
Dr. Agarwals Health Care Ltd
Dr. Agarwals Health Care Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with a presentation available on its website. The company has provided a disclaimer stating that the presentation is for general information purposes only and does not constitute an offer or invitation to purchase or sell securities.
Dr. Agarwals Health Care Ltd
Dr. Agarwal's Health Care Limited has announced its unaudited consolidated financial results for the quarter ended June 30, 2026, with revenue from operations growing by 26.0% YoY to ₹614 Crores, and PAT growing by 44.6% YoY to ₹55 Crores.
Dr. Agarwals Health Care Ltd
Dr. Agarwal's Health Care Ltd has announced its unaudited consolidated financial results for Q1 FY2027, with revenue from operations growing by 26.0% YoY to ₹614 Crores, and PAT growing by 44.6% YoY to ₹55 Crores. The company has also announced the appointment of new auditors, internal auditors, and cost auditors, and the incorporation of a wholly owned subsidiary in Nigeria.
Dr. Agarwals Health Care Ltd
Dr. Agarwals Health Care Ltd will host an earnings conference call on August 4, 2026, to discuss its unaudited financial results for the quarter ended June 30, 2026.
Dr. Agarwals Health Care Ltd
Dr. Agarwals Health Care Ltd has scheduled a board meeting on August 4, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026. The company will also host an earnings/analyst conference call on the same day.